Latest Financial Performance And Outlook News

Tamboran Resources Corporation reported a 26% reduction in half-year losses as it progresses key natural gas projects in Australia’s Beetaloo Basin and prepares for a major acquisition of Falcon Oil & Gas Ltd.

BluGlass Limited has extended its contract with the U.S. Department of War by A$1.05 million and appointed a refreshed Board to accelerate its commercial growth in visible laser technology. The company is advancing its GaN laser portfolio amid a US$100 million project pipeline and ongoing R&D investments.

Swoop Holdings Limited showcased robust subscriber growth and strategic divestments at its November 2025 AGM, targeting significant margin improvements and operational efficiencies.

LGI Limited reported robust FY25 results, expanding electricity capacity by 44% and increasing EBITDA by 14%, driven by new landfill gas contracts and battery storage projects. The company is well positioned to capitalize on Australia’s renewable energy transition and evolving carbon credit market.

KMD Brands reported a challenging FY25 with a net loss but has launched a transformative ‘Next Level’ strategy focused on cost reset, product innovation, and digital growth. Early FY26 trading shows promising sales momentum, signaling potential turnaround.

Kincora Copper Limited has closed a C$4 million non-brokered financing and expanded its exploration portfolio with eight active projects, advancing drilling programs alongside major partners. The company reported a net loss of CAD 2.786 million for the nine months ended September 30, 2025.

AXP Energy has drilled its inaugural vertical well in Oklahoma following a significant lease acquisition and raised A$2.7 million to fund exploration, while production in Colorado declined due to operational challenges.

Fluence Corporation reported a robust 72.9% revenue increase in Q3 2025, driven by a strategic pivot towards higher-margin Smart Product Solutions and recurring revenue streams. The company maintains its full-year guidance despite expecting to finish near the lower end.

Dyno Nobel has finalised the sale of its Fertilisers Distribution business and is advancing strategic shifts including a new US TNT manufacturing partnership, underpinning a strong FY25 outlook.

Paradigm Biopharmaceuticals marked FY25 with the launch of its global Phase 3 trial for its osteoarthritis drug iPPS, backed by strong FDA protocol approval and a $41 million funding facility. The company also broadened its pipeline with the acquisition of Pentacoxib™, targeting early-stage OA.

Bank of Queensland announces a potential $3.8 billion equipment finance loan sale and a strategic AI partnership with Capgemini, aiming to enhance capital efficiency and cut costs. The bank updates FY25 earnings guidance while withdrawing specific FY26 targets amid ongoing uncertainty.

Accent Group reported a modest 0.8% increase in FY2025 total sales to $1.62 billion, while profits dipped slightly. The company is advancing its store expansion and brand portfolio, targeting strong EBIT growth in FY26 despite startup costs.